Triggered by ultrasound, microbubbles open the blood-brain barrier to administer drugs without harming other areas of the body
December 2, 2016
Using ultrasound to bypass the blood-brain barrier (BBB), Columbia University researchers have succeeded in releasing drugs only in the specific area of the brain where they are needed — not in the rest of the body. The goal is to help treat Parkinson’s, Alzheimer’s, and other neurodegenerative diseases without collateral damage.
The BBB is an impassable obstacle for 98% of drugs, which it treats as pathogens and… read more